NoaG.HoltzmanMD

PubMed

• Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA.
  Yifan Pang, Temesgen E Andargie, Moon Kyoo Jang, Hyesik Kong, Woojin Park, Thomas Hill, Neelam Redekar, Yi-Ping Fu, Desai A Parth, Noa G Holtzman, Steven Z Pavletic, S...> ;Iscience. 2023 Nov 17
• W"H-Y" antigen/HLA complexes in chronic GVHD.
  Noa G Holtzman, Steven Z Pavletic> ;Blood. 2023 Sep 14
• Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.
  Aaron T Zhao, Filip Pirsl, Seth M Steinberg, Noa G Holtzman, Eduard Schulz, Alain Mina, Jacqueline W Mays, Edward W Cowen, Leora E Comis, Galen O Joe, Jack A Yanovski,...> ;Bone Marrow Transplantation. 2023 Dec 1
• Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
  David Beshensky, Filip Pirsl, Noa G Holtzman, Seth M Steinberg, Jacqueline W Mays, Edward W Cowen, Leora E Comis, Galen O Joe, M Teresa Magone, Eduard Schulz, Meryl A ...> ;Bone Marrow Transplantation. 2023 Oct 1
• Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.
  Yifan Pang, Noa G Holtzman> ;Best Practice & Research. Clinical Haematology. 2023 Jun 1
• A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.
  Yifan Pang, Ananth V Charya, Michael B Keller, Arlene Sirajuddin, Yi-Ping Fu, Noa G Holtzman, Steven Z Pavletic, Sean Agbor-Enoh> ;Blood Advances. 2022 Sep 13
• 1 citations
  Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.
  Ana Zelic Kerep, Filip Pirsl, Seth Steinberg, Sandra Mitchell, Lauren Curtis, Noa Holtzman, Sencer Goklemez, Ervina Bilic, Edward Cowen, Dominique Pichard, Galen Joe, ...> ;Hemasphere. 2022 Jun 1
• 3 citations
  The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.
  Yifan Pang, Ananth V Charya, Michael B Keller, Arlene Sirajuddin, Yi-Ping Fu, Noa G Holtzman, Steven Z Pavletic, Sean Agbor-Enoh> ;Blood Advances. 2022 Jul 26
• 2 citations
  CAR T-cell therapy for indolent lymphoma: a new treatment paradigm?
  Noa G Holtzman, Nirali N Shah> ;The Lancet. Oncology. 2022 Jan 1
• 7 citations
  The clinical landscape of chronic graft-versus-host disease management in 2021.
  Noa G. Holtzman, Steven Z. Pavletic> ;British Journal of Haematology. 2021 Oct 2
• 9 citations
  The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
  Forat Lutfi, Noa G. Holtzman, Ankit Kansagra, Moaath K. Mustafa Ali, Ali Bukhari, Jingsheng Yan, Santanu Samanta, David Gottlieb, Dong Won Kim, Lisa R. Matsumoto, Nata...> ;British Journal of Haematology. 2021 Sep 9
• 4 citations
  Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
  Sencer Goklemez, Leorey N. Saligan, Filip Pirsl, Noa G. Holtzman, Alen Ostojić, Seth M. Steinberg, Frances T. Hakim, Jeremy J. Rose, Zhigang Kang, Yunkai Yu, Liang Cao...> ;Bone Marrow Transplantation. 2021 Aug 25
• 4 citations
  Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease
  Dana A. Schaar, Filip Pirsl, Noa G. Holtzman, Seth M. Steinberg, Jeannette Nashed, Claire L. Ruben, Edward W. Cowen, Jacqueline W. Mays, Sandra A. Mitchell, Alen Ostoj...> ;Transplantation and Cellular Therapy. 2021 Aug 8
• 2 citations
  FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
  Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Ivana Gojo, Jonathan Webster, Kelly J. Norsworthy, B ...> ;Biology. 2021 Mar 21
• 3 citations
  Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
  Sarah M. Kashanian, Noa G. Holtzman, Ciera L Patzke, Jonathan Cornu, Alison Duffy, Madhurima Koka, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Jummai Apata, Farin ...> ;Cancer Chemotherapy and Pharmacology. 2021 Mar 7
• Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
  Claire L. Ruben, Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Laura Parsons-Wandell, Judy Baruffaldi, Lauren M. Curtis, Sandra A. Mitchell, Ana Zelic Kerep, Edward...> ;Bone Marrow Transplantation. 2021 Feb 1
• 4 citations
  Increased body mass index is a risk factor for acute promyelocytic leukemia.
  Sarah M. Kashanian, Andrew Y. Li, Moaath Mustafa Ali, Mark E. Sutherland, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Firas El Chaer, Noa G. Holtzman, Mohammad Imra...> ;Ejhaem. 2021 Jan 6
• 1 citations
  Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
  Noa G Holtzman, Michael S Lebowitz, Rima Koka, Maria R Baer, Kanam Malhotra, Amir Shahlaee, Hossein A Ghanbari, Søren M Bentzen, Ashkan Emadi> ;Frontiers in Oncology. 2021 Jan 1
• 12 citations
  Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
  Forat Lutfi, Noa G. Holtzman, Jonathan Siglin, Ali Bukhari, Moaath Mustafa Ali, Dong Kim, Gabriela Sanchez-Petitto, David Gottlieb, Kathleen Ruehle, Elizabeth Hutnick,...> ;British Journal of Haematology. 2021 Jan 1
• 5 citations
  Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy
  Ilana Schlam, Noa G. Holtzman, Monica Peravali, Perry K. Richardson, Saurabh Dahiya, Vera Malkovska, Aaron P. Rapoport> ;Blood Advances. 2020 Dec 8
• 14 citations
  A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
  Lauren M. Curtis, Alen Ostojić, David Venzon, Noa G. Holtzman, Filip Pirsl, Zoya Kuzmina, Kristin Baird, Jeremy J. Rose, Edward W. Cowen, Jacqueline W. Mays, Sandra A....> ;Blood. 2021 Feb 18
• 40 citations
  Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantat...
  Bhagirathbhai Dholaria, Bipin N. Savani, Betty K. Hamilton, Betul Oran, Hien D. Liu, Martin S. Tallman, Stefan O. Ciurea, Noa G. Holtzman, Gordon L. Phillips, Steven M...> ;Transplantation and Cellular Therapy. 2021 Jan 1
• 43 citations
  Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
  Noa G. Holtzman, Hao Xie, Søren M. Bentzen, Vivek Kesari, Ali Bukhari, Firas El Chaer, Forat Lutfi, Jonathan Siglin, Elizabeth Hutnick, Natalie Gahres, Kathleen Ruehle...> ;Neuro-Oncology. 2021 Jan 30
• 1 citations
  Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore
  Andrew Y. Li, Sarah M. Kashanian, Bryan C. Hambley, Kyle Zacholski, Maria R. Baer, Vu H. Duong, Firas El Chaer, Noa G. Holtzman, Kelly J. Norsworthy, Mark J. Levis, B....> ;Leukemia & Lymphoma. 2020 Jun 14
• 3 citations
  Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma.
  Firas El Chaer, Ariel Siegel, Noa G. Holtzman, Ali Bukhari, Forat Lutfi, Nirav Shah, Jean A. Yared, Aaron P. Rapoport, Michael T. McCurdy, Saurabh Dahiya> ;American Journal of Hematology. 2020 Jun 1
• Join now to see all

Abstracts/Posters

• Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
  Noa G. Holtzman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019